Kidney Week 2023: Exhibitor Spotlight Schedule
Thursday, November 2 - Saturday, November 4
Pennsylvania Convention Center, Exhibit Hall B (Enter at Exhibit Hall C)
Join your colleagues for the latest advances in nephrology practices, products, services, and technologies presented in two theaters on the exhibit hall floor. Seating is limited and available on a first-come, first-served basis to fully registered Kidney Week participants only. Exhibitor Spotlights are not CE (continuing education) activities.
The 10:00 a.m. presentations include breakfast. All other presentations include lunch.
Thursday, November 2
10:00 a.m. - 10:45 a.m.
The Dual Dilemma: Navigating Cardiorenal Risk in CKD Associated with T2D
Presented by Bayer
11:00 a.m. - 11:45 a.m.
IgA Nephropathy: Where We Are Now and Where We Are Going
Presented by Chinook Therapeutics, A Novartis Company
12:00 p.m. - 12:45 p.m.
Replacing RASi in IgA Nephropathy: Insights into a Unique Therapy that Targets Two Pathways, with a Patient's Perspective
Presented by Travere Therapeutics
1:00 p.m. - 1:45 p.m.
Terlipressin and Albumin Use in Hepatorenal Syndrome
Presented by Mallinckrodt Pharmaceuticals
Friday, November 3
10:00 a.m. - 10:45 a.m.
Guideline Considerations for Early Treatment in Lupus Nephritis & Latest Updates in the Management of Anemia Due to Chronic Kidney Disease (CKD)
Presented by GSK
11:00 a.m. - 11:45 a.m.
A New Paradigm: Rethinking Hyperphosphatemia Management
Presented by Ardelyx, Inc.
12:00 p.m. - 12:45 p.m.
Overcoming the Challenges of Phosphate Management with a High-Potency Approach
Presented by Fresenius Medical Care Renal Pharmaceuticals
1:00 p.m. - 1:45 p.m.
Early Identification and Management in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Featuring Dialogue With a Patient Ambassador
Presented by Otsuka America Pharmaceutical, Inc.
Saturday, November 4
10:00 a.m. - 10:45 a.m.
Understanding the Complexity of Patients With CKD: Implications for Management
Presented by AstraZeneca
11:00 a.m. - 11:45 a.m.
A Closer Look at Kidney Preservation in Lupus Nephritis
Presented by Aurinia Pharmaceuticals
12:00 p.m. - 12:45 p.m.
Jardiance® (empagliflozin) tablets: A Peer Review of the Latest Clinical Data and Dosing Recommendations
Presented by Boehringer Ingelheim Pharmaceuticals, Inc./ Lilly USA
1:00 p.m. - 1:45 p.m.
Genetics in Nephrology: What Are We Missing?
Presented by Natera
*Additional information available by clicking on presentation title if provided by supporter.